Lack of sufficient information on the specificity and selectivity of commercial phytoestrogens preparations for therapeutic purposes

Maturitas

Volumn 68, Issue 1, 2011, Pages 56-64

  Leclercq, Guy ^a   De Cremoux, Patricia ^b   This, Pascale ^b   Jacquot, Yves ^c  

^a JULES BORDET INSTITUTE   (Belgium)

^b INSTITUT CURIE   (France)

^c Centre National de la Recherche Scientifique   (France)

Author keywords

Phytoestrogen; Selectivity; Specificity

Indexed keywords

6 HYDROXYFLAVONE; ALDEHYDE REDUCTASE; APIGENIN; AROMATASE; BIOCHANIN A; CELL NUCLEUS RECEPTOR; COUMESTROL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DAIDZEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EQUOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVANONE; FLAVONE; FORMONONETIN; G PROTEIN COUPLED RECEPTOR 30; GENISTEIN; GLYCITEIN; HYDROCORTISONE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHYTOESTROGEN; RESVERATROL; RETINOID X RECEPTOR; TAMOXIFEN; UNINDEXED DRUG; VITAMIN D RECEPTOR; VOLTAGE GATED SODIUM CHANNEL;

ADIPOGENESIS; BINDING AFFINITY; BONE DEVELOPMENT; BREAST CANCER; CHEMICAL ANALYSIS; DNA FRAGMENTATION; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN SYNTHESIS; HEALTH SURVEY; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PHYSICIAN; PROTEIN STRUCTURE; REVIEW; SOYBEAN MILK; STEROIDOGENESIS; STRUCTURE ANALYSIS;

EID: 78650589344     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.10.003     Document Type: Review

References (99)

1. Y. Jacquot, C. Rojas, B. Refouvelet, J.F. Robert, G. Leclercq, and A. Xicluna Recent advances in the development of phytoestrogens and derivatives: an update of the promising perspectives in the prevention of postmenopausal diseases Mini Rev Med Chem 3 5 2003 387 400
2. G.G.J.M. Kuiper, J.G. Lemmen, and B.O. Carlson Interaction of estrogenic chemical and phytoestrogens with estrogen receptor β Endocrinology 139 10 1998 4252 4263
3. G.N. Nikov, N.E. Hopkins, S. Boue, and W.L. Alworth Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor - estrogen response element complex formation Environ Health Perspect 108 9 2000 867 872
4. E.S. Manas, Z.B. Xu, R.J. Unwalla, and W.S. Somers Understanding the selectivity of genistein for human estrogen receptor beta using X-ray crystallography and computational methods Structure 12 12 2004 2197 2207
5. E. Reiter, V. Beck, S. Medjakovic, and A. Jungbauer Isoflavones are safe compounds for therapeutical applications - evaluation of in vitro data Gynecol Endocrinol 25 9 2009 554 580
6. E.J. Yearley, E.A. Zhurova, V.V. Zhurov, and A. Pinkerton Binding of genistein to the estrogen receptor based on an experimental electron density study J Am Chem Soc 129 48 2007 15013 15021
7. H. Sugiyama, T. Kumamoto, and A. Suganami Insight into estrogenicity of phytoestrogens using in silico simulation Biochem Biophys Res Commun 379 1 2009 139 144
8. D. Carusi Phytoestrogens as hormone replacement therapy: an evidence-based approach Prim Care Update Obstet/Gynecol 7 6 2000 253 259
9. D. Lukaczer, G. Darland, and M. Tripp Clinical effects of a proprietary combination isoflavone nutritional supplements in menopausal women: a pilot trial Altern Ther Health Med 11 5 2005 60 65
10. North America Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2008;14(3):11-33.
11. P. de Cremoux, P. This, G. Leclercq, and Y. Jacquot Controversies concerning the use of phytoestrogens in menopause management: bioavailability and metabolism Maturitas 65 4 2010 334 339
12. J.F. Couse, J. Lindzey, K. Grandien, Gustafsson J., and K.S. Korach Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse Endocrinology 138 11 1997 4613 4621
13. J.V. Turner, S. Agatonovic-Kustrin, and B.D. Glass Molecular aspects of phytoestrogen selective binding at estrogen receptors J Pharm Sci 96 8 2007 1879 1885
14. A.C.W. Pike, A.M. Brzozowski, and R.E. Hubbard A structural biologist's view of the estrogen receptor J Steroid Biochem Mol Biol 74 5 2000 261 268
15. E.J. Routledge, R. White, M.G. Parker, and J.P. Sumpter Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ J Biol Chem 275 46 2000 35986 35993
16. K.S. Bramlett, Y. Wu, and T.P. Burris Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes Mol Endocrinol 15 6 2001 909 922
17. D.M. Harris, E. Besselink, S.M. Henning, V.L.W. Go, and D. Heber Phytoestrogens induce differential estrogen receptor alpha- or beta-mediated responses in transfected breast cancer cells Exp Biol Med 230 8 2005 558 568
18. A.M. Sotoca, D. Ratman, and P. van der Saag Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on ERα/ERβ ratio J Steroid Biochem Mol Biol 112 4-5 2008 171 178
19. O. Treeck, C. Lattrich, A. Springwald, and O. Ortmann Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells Breast Cancer Res Treat 120 3 2010 557 565
20. M.L. de Lemos Effects of soy phytoestrogens genistein and daidzein on breast cancer growth Ann Pharmacother 35 9 2001 1118 1121
21. J.M. Guo, B.X. Xiao, and D.H. Liu Biphasic effect of daidzein on cell growth of human colon cancer cells Food Chem Toxicol 42 10 2004 1641 1646
22. J.M. Guo, B.X. Xiao, D.J. Dai, Q. Liu, and H.H. Ma Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro World J Gastroenterol 10 6 2004 860 863
23. C.Y. Hsieh, R.C. Santell, S.Z. Hasiam, and W.G. Helferich Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo Cancer Res 58 17 1998 3833 3838
24. C.D. Allred, K.F. Allred, Y.H. Ju, S.M. Virant, and W.G. Helferich Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner Cancer Res 61 13 2001 5045 5050
25. H. Schwartz, G. Sontag, and J. Plumb Inventory of phytoestrogen databases Food Chem 113 3 2009 736 747
26. W. Cherdshewasart, S. Sriwatcharakul, and S. Malaivijitnond Variance of estrogenic activity of the phytoestrogen-rich plant Maturitas 61 4 2008 350 357
27. K.D.R. Setchell, N.M. Brown, and P. Desai Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements J Nutr 131 4 2001 1362S 1375S
28. C.S. Watson, A.L. Bulayeva, A.L. Wozniak, and R.A. Alyea Xenoestrogens are potent activators of nongenomic estrogenic responses Steroids 72 2 2007 124 134
29. C.M. Klinge, K.A. Blankenship, and K.E. Risinger Resveratrol and estradiol rapidly activate MAPK signaling trough estrogen receptors α and β in endothelial cells J Biol Chem 280 9 2005 7460 7468
30. S. Rice, and S.A. Whitehead Phytoestrogens and breast cancer-promoters or protectors? Endocr Relat Cancer 13 4 2006 995 1015
31. T. Akiyama, J. Ishida, and S. Nakagawa Genistein, a specific inhibitor of tyrosine-specific protein kinases J Biol Chem 262 12 1987 5592 5595
32. X. Huang, S. Chen, and L. Xu Genistein inhibits p38 MAP kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells Cancer Res 65 8 2005 3470 3478
33. Z.H. Zhang, and Q. Wang Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein Pflugers Arch 440 5 2000 784 792
34. Z. Jia, Y. Jia, and B. Liu Genistein inhibits voltage-gated sodium currents in SCG neurons through protein tyrosine kinase-dependent and kinase-independent mechanisms Pflugers Arch 456 5 2008 857 866
35. P.H.M. Peeters, N. Slimani, and Y.T. van der Schouw Variations in plasma phytoestrogen concentrations in european adults J Nutr 137 5 2007 1294 1300
36. H. Stopper, E. Schmitt, and K. Kobras Genotoxicity of phytoestrogens Mutat Res 574 1-2 2005 139 155
37. S.E. Kulling, B. Rosenberg, E. Jacobs, and M. Metzler The phytoestrogens coumoestrol and genistein induce structural chromosomal aberrations in cultured human peripheral blood lymphocytes Arch Toxicol 73 1 1999 50 54
38. J. Markovits, C. Linassier, and P. Fosse Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II Cancer Res 49 18 1989 5111 5117
39. C. Vissac-Sabatier, V. Coxam, and P. Déchelotte Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats Cancer Res 63 20 2003 6607 6612
40. B. Caëtano, L. Le Corre, N. Chalabi, L. Delort, Y.J. Bignon, and D.J. Bernard-Gallon Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosupressors in human breast cell lines Br J Nutr 95 2 2006 406 413
41. S. Ohno, S. Shinoda, S. Toyoshima, H. Nakazawa, T. Makino, and S. Nakajin Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells J Steroid Biochem Mol Biol 80 3 2002 355 363
42. S. Ohno, N. Matsumoto, M. Watanabe, and S. Nakajin Flavonoid inhibition of overexpresses human 3beta-hydroxysteroid dehydrogenase type II J Steroid Biochem Mol Biol 88 2 2004 175 182
43. L. Skarydová, L. Zivná, G. Xiong, E. Maser, and V. Wsól ARK1C3 as a potential target for the inhibitory effect of dietary flavonoids Chemico-Biol Interact 178 1-3 2009 138 144
44. A. Krazeisen, G. Breitling, G. Möller, and J. Adamski Phytoestrogens inhibit human 17β-hydroxysteroid dehydrogenase type 5 Mol Cell Endocrinol 171 1-2 2001 151 162
45. J.T. Sanderson, J. Hordijk, M.S. Denison, M.F. Springsteel, M.H. Nantz, and M. van den Berg Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells Toxicol Sci 82 1 2004 70 79
46. S.M. Mense, T.K. Hei, R.K. Ganju, and H.K. Bhat Phytoestrogens and breast cancer prevention: possible mechanism of action Environ Health Perspect 116 4 2008 426 433
47. Z. Huang, M.J. Fasco, and L.S. Kaminsky Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids J Steroid Biochem Mol Biol 63 1-3 1997 9 15
48. Z.C. Dang, and C.W.G.M. Löwik The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis J Bone Miner Res 19 5 2004 853 861
49. Z.C. Dang, V. Audinot, S.E. Papapoulos, J.A. Boutin, and C.W.G.M. Löwik Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein J Biol Chem 278 2 2003 962 967
50. S. Kim, I. Sohn, Y.S. Lee, and Y.S. Lee Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity J Nutr 135 1 2005 33 41
51. H. Ashida Suppressive effects of flavonoids on dioxin toxicity Biofactors 12 1-4 2008 201 206
52. E. Van der Heiden, N. Bechoux, M. Muller, T. Sergent, Y.J. Schneider, and Y. Larondelle Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays Anal Chim Acta 637 1-2 2009 337 345
53. C. Duffy, K. Perez, and A. Partridge Implications of phytoestrogen intake for breast cancer CA Cancer J Clin 57 5 2007 260 277
54. H.S. Seo, D.G. DeNardo, and Y. Jacquot Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha Breast Cancer Res Treat 99 2 2006 121 134
55. W.G. Helferich, J.E. Andrade, and M.S. Hoagland Phytoestrogens and breast cancer: a complex story Inflammopharmacology 16 5 2008 219 226
56. C.H. Liao, S.L. Pan, J.H. Guh, and C.M. Teng Genistein inversely affects tubulin-binding agent-induced apoptosis in human breast cancer cells Biochem Pharmacol 67 11 2004 2031 2038
57. H. Taylor, E.M. Quintero, A.M. Iacopino, and E.D. Lephart Phytoestrogens alter hypothalamic calbindin-D28k levels during prenatal development Brain Res Dev Brain Res 114 2 1999 277 281
58. S. Martinez-Luis, A. Pérez-Vasquez, and R. Mata Natural products with calmodulin inhibitor properties Phytochemistry 68 14 2007 1882 1903
59. A. Kazi, G.D. Kenyon, D.M. Smith, N.B. Kumar, and Q.P. Dou Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein Biochem Pharmacol 66 6 2003 965 976
60. M.D. Siegelin, Y. Siegelin, A. Habel, and T. Gaiser Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis Neurosci Lett 453 2 2009 92 97
61. M.P. Warren The effects of phytoestrogen supplementation in postmenopausal women J Soc Gynecol Invest 9 4 2002 184 185
62. K.W. Heaton, and S.J. Lewis Phyto-oestrogens and breast cancer Lancet 351 9096 1998 137 139
63. L.A. Fitzpatrick Soy isoflavones: hope or hype? Maturitas 44 suppl.1 2003 S21 S29
64. M.S. Kurzer Phytoestrogen supplement used by women J Nutr 133 6 2003 1983S 1986S
65. C.L. van Patten, I.A. Olivotto, and K. Chambers Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial J Clin Oncol 20 6 2002 1449 1455
66. M. Messina, W. McCaskill-stevens, and J.W. Lampe Adressing the soy and breast cancer relationship: review, commentary, and workshop proceedings J Natl Cancer Inst 98 18 2006 1275 1284
67. W. Wuttke, H. Jarry, and D. Seidlová-Wuttke Isoflavones - safe food additives or dangerous drugs? Ageing Res Rev 6 2 2007 150 188
68. L.S. Velentzis, J.V. Woodside, M.M. Cantwell, A.J. Leathem, and M.R. Keshtgar Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know Eur J Cancer 44 13 2008 1799 1806
69. S.J. Kwack, H.S. Kim, K.S. Yoon, and B.M. Lee Risk assessment of soybean-based phytoestrogens J Toxicol Environ Health, Part A 72 21-22 2009 1254 1261
70. A.M. Brzozowski, A.C.W. Pike, and Z. Dauter Molecular basis of agonism and antagonism in the oestrogen receptor Nature 389 6652 1997 753 758
71. W. Humphrey, A. Dalke, and K. Schulten VMD - visual molecular dynamics J Mol Graph 14 1 1996 33 38
72. S. Chennaiah, V. Vijayalakshmi, and C. Suresh Effect of supplementation of dietary rich phytoestrogens in altering vitamin D levels in diet induced osteoporotic rat model J Steroid Biochem Mol Biol 121 1-2 2010 268 272
73. S. Segaert, S. Courtois, M. Garmyn, H. Degreef, and R. Bouillon The flavonoid apigenin supresses vitamin D receptor expression and vitamin D responsiveness in normal human keratinocytes Biochem Biophys Res Commun 268 1 2000 237 241
74. H. Wang, H. Li, and L.B. Moore The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor Mol Endocrinol 22 4 2008 838 857
75. K. Szkudelska, L. Nogowski, and T. Szkudelski Genistein affects lipogenesis and lipolysis in isolated rat adipocytes J Steroid Biochem Mol Biol 75 4-5 2000 265 271
76. K. Szkudelska, and L. Nogowski Genistein - a dietary compound inducing hormonal and metabolic changes J Steroid Biochem Mol Biol 105 1-5 2007 37 45
77. S. Rice, H.D. Mason, and S.A. Whitehead Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells J Steroid Biochem Mol Biol 101 4-5 2006 216 225
78. H. Liu, J. Du, and C. Hu Delayed activation of extracellular-signal- regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells J Nutr Biochem 21 5 2009 390 396
79. 10 pituitary tumor cells J Mol Signal 4 2 2009 doi:10.1186/1750-2187-4-2
80. O. Kousidou, G.N. Tzanakakis, and N.K. Karamanos Effects of the natural isoflavonoid genistein on growth, signaling pathways and gene expression of matrix macromolecules by breast cancer cells Mini-Rev Med Chem 6 3 2006 331 337
81. + exchange in human platelets Arch Physiol Biochem 108 5 2000 429 436
82. D.A. Jacob, J.L. Temple, H.B. Patisaul, L.J. Young, and E.F. Rissman Coumestrol antagonizes neuroendocrine actions of estrogen via the estrogen receptor alpha Exp Biol Med (Maywood) 226 4 2001 301 306
83. Y. Toyohira, S. Ueno, and M. Tsutsui Stimulatory effects of the soy phytoestrogen genistein on noradrenaline transporter and serotonin transporter activity Mol Nutr Food Res 54 4 2010 516 524
84. I. Woclawek-Potocka, K. Okuda, T.J. Acosta, A. Korzekwa, W. Pilawski, and D.J. Skarzynski Phytoestrogen metabolites are much more active than phytoestrogens themselves in increasing prostaglandin F2α synthesis via prostaglandin F2α synthase-like 2 stimulation in bovine endometrium Prostaglandins Other Lipid Mediat 78 1-4 2005 202 217
85. T. Hertrampf, S. Schmidt, U. Laudenbach-Leschowsky, J. Seibel, and P. Diel Tissue-specific modulation of cyclooxygenase (Cox-2) expression in the uterus and v. cava by estrogens and phytoestrogens Mol Cell Endocrinol 243 1-2 2005 51 57
86. S. Yellayi, A. Naaz, and M.A. Szewczykowski The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci USA 99 11 2002 7616 7621
87. L. Lehmann, H.L. Esch, J. Wagner, L. Rohnstock, and M. Metzler Estrogenic and genotoxicity potential of equol and two hydroxylated metabolites of daidzein in cultured human Ishikawa cells Toxicol Lett 158 1 2005 72 86
88. +/- human lymphoblastoid cells Mut Res 474 1-2 2001 129 137
89. E. Schmitt, M. Metzler, R. Jonas, W. Dekant, and H. Stopper Genotoxic activity of four metabolites of the soy isoflavone daidzein Mut Res 542 1-2 2003 43 48
90. A.L. Di Virgillio, K. Iwami, W. Wätjen, R. Kahl, and G.H. Degen Genotoxicity of the isoflavones genistein, daidzein and equol in V79 cells Toxicol Lett 151 1 2004 151 162
91. R. Michael McClain, E. Wolz, A. Davidovich, and J. Bausch Genetic toxicity studies with genistein Food Chem Toxicol 44 1 2006 42 55
92. M. Asahi, S. Yanagi, and S. Ohta Thrombin-induced human platelet aggregation is inhibited by protein-kinase inhibitors, ST638 and genistein FEBS 309 1 1992 10 14
93. S. Vyas, Y. Asmerom, and D.D. León Resveratrol regulates insulin-like growth factor II in breast cancer cells Endocrinology 146 10 2005 4224 4233
94. E. Padilla-Banks, W.N. Jefferson, and R.R. Newbold Neonatal exposure to the phytoestrogen genistein alters mammary gland growth and developmental programming of hormone receptor level Endocrinology 147 10 2006 4871 4882
95. S. Hongwei, L. Dongmin, and Genistein a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats J Nutr 138 2 2008 297 304
96. M. Yamaguchi, and M.N. Weitzmann The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity Int J Mol Med 23 2 2009 297 301
97. A.M. Pino, L.E. Valladares, M.A. Palma, A.M. Mancilla, M. Yáñes, and C. Albala Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women J Clin Endocrinol Metab 85 8 2000 2797 2800
98. Y.S. Kim, N.H. Kim, D.H. Jung, D.S. Jang, Y.M. Lee, and J.M. Kim Genistein inhibits aldose reductase activity and high glucose-induced TGF-β2 expression in human lens epithelial cells Eur J Pharmacol 594 1-3 2008 18 25
99. E. Cecchi, F. Lapi, A. Vannacci, G. Banchelli, T. Mazzei, and A. Mugelli Increased levels of CA 125 and CA 19.9 serum tumour markers following cyclic combined hormone replacement therapy J Clin Pharm Therap 34 1 2009 129 132